カテゴリ： GlobalData, アメリカ, 企業調査

NanoString Technologies Inc (NSTG)-医療機器分野：企業M&A・提携分析

◆英語タイトル：NanoString Technologies Inc (NSTG) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA8011250
◆発行会社（調査会社）：GlobalData
◆発行日：2017年12月22日
◆ページ数：71
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
NanoString Technologies Inc (NanoString) is a provider of life science products and tools for translational research and molecular diagnostics. The company’s products portfolio includes sprint profiler, Dx analysis system with flex, MAX analysis system, protein assays, solid tumor assays, gene fusion panels, RNA panels, DNA assays, immunology panel, gene expression codesets, pancancer immune profiling and pathways among others. NanoString’s nCounter analysis system provides cost-effective method to profile hundreds of miRNA, miRGE or DNA molecules simultaneously employing digital molecular barcoding technology. The company sells its products through direct sales force and distributors in the US, Europe, the Middle East and Asia-Pacific. NanoString is headquartered in Seattle, Washington, the US.

NanoString Technologies Inc (NSTG) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
NanoString Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
NanoString Technologies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
NanoString Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
NanoString Technologies Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
NanoString Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
NanoString Technologies Inc, Medical Equipment, Deal Details 12
Venture Financing 12
NanoString Technologies Raises US$0.2 Million In Venture Financing 12
NanoString Technologies Raises US$15 Million In Series E Financing 13
NanoString Technologies To Raise US$0.65 Million In Venture Financing 15
NanoString Technologies Secures US$20 Million In Series D Financing 16
NanoString Technologies Secures US$2.5 Million In Venture Financing 17
Partnerships 18
NanoString Technologies Enters into Distribution Agreement with SAM Laboratory 18
NanoString Technologies Enters into Agreement with NSABP Foundation 19
NanoString Technologies Enters into Agreement with OHSU Knight Cancer Institute 20
NanoString Technologies Enters into Co-Development Agreement with HalioDx 21
NanoString Technologies Enters into Agreement with Cell Signaling Technology 22
Medivation and NanoString Technologies Enters into Partnership With Astellas Pharma 23
NanoString Enters into Research Agreement with CITN for Novel Cancer Immunotherapies 24
NanoString Enters into Co-Development Agreement with MD Anderson Cancer Center 25
NanoString Enters into Research Agreement with Brigham and Women’s Hospital 26
NanoString Enters into Co-Development Agreement with Celgene 27
NanoString Technologies Enters Into Option Agreement With Broad Institute To License Liver Cancer Gene Signature 28
Equity Offering 29
NanoString Technologies Plans to Raise USD100 Million in Public Offering of Shares 29
NanoString Technologies Raises USD57.8 Million in Public Offering of Shares 30
NanoString to Raise USD40 Million in Public Offering of Shares 32
NanoString Technologies Completes Public Offering Of Shares For US$55 Million 33
NanoString Technologies Completes IPO Of Shares For US$54 Million 35
NanoString Technologies Inc – Key Competitors 37
NanoString Technologies Inc – Key Employees 38
NanoString Technologies Inc – Locations And Subsidiaries 39
Head Office 39
Recent Developments 40
Financial Announcements 40
May 04, 2017: NanoString Technologies Releases Operating Results for First Quarter of 2017 40
Mar 01, 2017: NanoString Technologies Releases Fourth Quarter and Full Year 2016 Operating Results and Provides 2017 Outlook 41
Jan 10, 2017: NanoString Technologies Provides Preliminary Operational and Financial Results for 2016 42
Nov 02, 2016: NanoString Technologies Releases Operating Results for Third Quarter of 2016 43
Aug 03, 2016: NanoString Technologies Releases Operating Results for Second Quarter of 2016 44
May 05, 2016: NanoString Technologies Releases Operating Results for First Quarter of 2016 45
Feb 29, 2016: NanoString Technologies Releases Fourth Quarter and Full Year 2015 Financial Results and Provides 2016 Outlook 46
Jan 10, 2016: NanoString Technologies Provides Preliminary Operational and Financial Results for 2015 48
Corporate Communications 49
May 10, 2017: NanoString Appoints Elisha W. Finney to Board of Directors 49
Sep 13, 2016: NanoString Technologies Appoints Kirk Malloy, Ph.D. to Board of Directors 50
Product News 51
Sep 18, 2017: NanoStrings Hyb & Seq Enables Liquid Biopsy by the Direct Capture and Sequencing of Cell-Free DNA 51
Apr 03, 2017: Digital Spatial Profiling Technology Enables Quantitative Protein Profiling in FFPE Tissue Providing Detailed Molecular Characterization of Immune Response to Tumors 52
Mar 29, 2017: NanoString Launches Multiple New Products at AACR 2017 to Advance Precision Oncology Research 54
Mar 27, 2017: NanoString Highlights a Record Number of nCounter-Based Research Abstracts in Precision Oncology and Predictive Biomarkers at the 2017 American Association of Cancer Research Annual Meeting 55
Mar 23, 2017: NanoString Launches New PlexSet Technology as an Alternative to qPCR for Multiplexed High-Throughput Gene Expression Studies 58
Feb 27, 2017: The Novartis Institutes for BioMedical Research and NanoString Technologies Demonstrate a Novel Approach for High-Plex 60
Feb 27, 2017: The Novartis Institutes for BioMedical Research and NanoString Technologies Demonstrates at 2017 ASCO-SITC Clinical Immuno-Oncology Symposium 61
Nov 30, 2016: NanoString Technologies Highlights Advances in Precision Oncology at the 58th Annual Meeting of the American Society of Hematology 62
Nov 18, 2016: NanoString Enhances Solid Tumor Profiling with 3D Biology Capabilities for Formalin-Fixed, Paraffin-Embedded (FFPE) Tissue Samples 64
Nov 07, 2016: NanoString Launches Technology Access Program (TAP) for Transformative Platform for High-Plex Digital Spatial Profiling 65
Jun 02, 2016: NanoString Technologies Highlights Advances in Precision Oncology and Immunotherapy at the 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) 66
Apr 14, 2016: NanoString Technologies Unveils New nCounter Vantage Assays to Power Cancer Research With 3D Biology 69
02/09/2016: American Society of Clinical Oncology Clinical Practice Guideline Recommends Use of Prosigna (PAM50) for Guiding Treatment Decisions in Early Stage Breast Cancer Patients 70
Appendix 71
Methodology 71
About GlobalData 71
Contact Us 71
Disclaimer 71

List of Tables
NanoString Technologies Inc, Medical Equipment, Key Facts, 2016 2
NanoString Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
NanoString Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
NanoString Technologies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
NanoString Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
NanoString Technologies Inc, Deals By Market, 2011 to YTD 2017 9
NanoString Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
NanoString Technologies Raises US$0.2 Million In Venture Financing 12
NanoString Technologies Raises US$15 Million In Series E Financing 13
NanoString Technologies To Raise US$0.65 Million In Venture Financing 15
NanoString Technologies Secures US$20 Million In Series D Financing 16
NanoString Technologies Secures US$2.5 Million In Venture Financing 17
NanoString Technologies Enters into Distribution Agreement with SAM Laboratory 18
NanoString Technologies Enters into Agreement with NSABP Foundation 19
NanoString Technologies Enters into Agreement with OHSU Knight Cancer Institute 20
NanoString Technologies Enters into Co-Development Agreement with HalioDx 21
NanoString Technologies Enters into Agreement with Cell Signaling Technology 22
Medivation and NanoString Technologies Enters into Partnership With Astellas Pharma 23
NanoString Enters into Research Agreement with CITN for Novel Cancer Immunotherapies 24
NanoString Enters into Co-Development Agreement with MD Anderson Cancer Center 25
NanoString Enters into Research Agreement with Brigham and Women’s Hospital 26
NanoString Enters into Co-Development Agreement with Celgene 27
NanoString Technologies Enters Into Option Agreement With Broad Institute To License Liver Cancer Gene Signature 28
NanoString Technologies Plans to Raise USD100 Million in Public Offering of Shares 29
NanoString Technologies Raises USD57.8 Million in Public Offering of Shares 30
NanoString to Raise USD40 Million in Public Offering of Shares 32
NanoString Technologies Completes Public Offering Of Shares For US$55 Million 33
NanoString Technologies Completes IPO Of Shares For US$54 Million 35
NanoString Technologies Inc, Key Competitors 37
NanoString Technologies Inc, Key Employees 38

★海外企業調査レポート[NanoString Technologies Inc (NSTG)-医療機器分野：企業M&A・提携分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • State Corporation Bank for Development and Foreign Economic Affairs：電力：M&Aディール及び事業提携情報
    Summary State Corporation Bank for Development and Foreign Economic Affairs (Vnesheconombank) is a bank that offers investment banking and funding services. The company funds and supports investment projects and industrial exports through credits, guarantees and sureties, economic entities authorize …
  • Kier Group plc (KIE)：企業の財務・戦略的SWOT分析
    Kier Group plc (KIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Classic Cosmetics, Inc：企業の戦略・SWOT・財務情報
    Classic Cosmetics, Inc - Strategy, SWOT and Corporate Finance Report Summary Classic Cosmetics, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Landstar System, Inc.：戦略・SWOT・企業財務分析
    Landstar System, Inc. - Strategy, SWOT and Corporate Finance Report Summary Landstar System, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Cooper Tire & Rubber Company：企業の戦略・SWOT・財務情報
    Cooper Tire & Rubber Company - Strategy, SWOT and Corporate Finance Report Summary Cooper Tire & Rubber Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Ypsomed Holding AG (YPSN)-医療機器分野：企業M&A・提携分析
    Summary Ypsomed Holding AG (Ypsomed) is a medical device company. It designs, develops and manufactures injection systems. Its offers pen injectors, autoinjectors, dual chamber pens and other custom products. The company also offers contract manufacturing, industrial design, human factors engineerin …
  • TOPS Markets, LLC：企業の戦略的SWOT分析
    TOPS Markets, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Corcept Therapeutics Inc (CORT)：企業の財務・戦略的SWOT分析
    Corcept Therapeutics Inc (CORT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • NR Electric Co Ltd：企業の戦略的SWOT分析
    NR Electric Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • MYnd Analytics Inc (MYND)：医療機器：M&Aディール及び事業提携情報
    Summary MYnd Analytics Inc (MYnd Analytics), formerly CNS Response Inc, is a predictive analytics company. The company develops a decision support tool that assists physicians in the provision of personalized medication for individual patients suffering from mental health issues. It provides Psychia …
  • North Eastern Electric Power Corporation Ltd：発電所・企業SWOT分析
    North Eastern Electric Power Corporation Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inf …
  • STR Holdings Inc：企業の戦略的SWOT分析
    STR Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Bank Of Ireland (Uk) Plc：企業の戦略・SWOT・財務分析
    Bank Of Ireland (Uk) Plc - Strategy, SWOT and Corporate Finance Report Summary Bank Of Ireland (Uk) Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • PowerStream Inc.-エネルギー分野：企業M&A・提携分析
    Summary PowerStream Inc. (PowerStream), a subsidiary of PowerStream Holdings, Inc., is a municipality-owned energy company that provides power and related services north of Toronto and in Central Ontario. The company is jointly owned by the municipality of Markham, municipality of Vaughan, and munic …
  • Northeastern Rural Electric Membership Corp：企業の戦略的SWOT分析
    Northeastern Rural Electric Membership Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Pelago Bioscience AB：製薬・医療：M&Aディール及び事業提携情報
    Summary Pelago Bioscience AB (Pelago Bioscience) is a developer of patented cellular thermal shift assay for use in determination and quantification of drug–target interactions. The company utilizes patented CETSA technology which enables direct, in situ physiologically relevant measurements of targ …
  • Isuzu Motors Ltd (7202)：企業の財務・戦略的SWOT分析
    Isuzu Motors Ltd (7202) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Micropole SA (MUN)：企業の財務・戦略的SWOT分析
    Micropole SA (MUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Energy Future Holdings Corp.-エネルギー分野：企業M&A・提携分析
    Summary Energy Future Holdings Corp. (EFH Corp) is an electric utility company. It manages a portfolio of competitive and regulated energy companies serving the Texas electricity market. The company’s competitive businesses consist of Luminant, which is involved in power generation and related minin …
  • SK Kaken Co Ltd (4628)：企業の財務・戦略的SWOT分析
    SK Kaken Co Ltd (4628) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆